학술논문
Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data
Document Type
Article
Author
Kimyon, G.; Kalyoncu, U.; Kiraz, S.; Kilic, L.; Bilgin, E.; Ertenli, I.; Karadag, O.; Bolek, E.C.; Farisogullari, B.; Yakkan, G.; Sari, A.; Armagan, B.; Bes, C.; Coskun, N.; Yagiz, B.; Dalkilic, E.; Pehlivan, Y.; Kucuksahin, O.; Kanitez, N.; Erden, A.; Erten, S.; Kasifoglu, T.; Bilge, S.Y.; Emmungil, H.; Ilgen, U.; Koca, S.S.; Karatas, A.; Akar, S.; Cinar, M.; Yilmaz, S.; Tekgoz, E.; Colak, S.; Yazisiz, V.; Terzioglu, E.; Ates, A.; Kelesoglu, B.; Ersozlu, D.; Gonullu, E.; Mercan, R.
Source
In: Clinical and Experimental Rheumatology . (Clinical and Experimental Rheumatology, July 2021, 39(4):852-858)
Subject
Language
English
ISSN
1593098X
0392856X
0392856X